- Home
- HKIT vs PYPD Comparison
HKIT vs PYPD Comparison
Compare HKIT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- PYPD
- Stock Information
- Founded
- HKIT 1996
- PYPD 2008
- Country
- HKIT China
- PYPD Israel
- Employees
- HKIT N/A
- PYPD N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- PYPD Medical/Dental Instruments
- Sector
- HKIT Technology
- PYPD Health Care
- Exchange
- HKIT Nasdaq
- PYPD Nasdaq
- Market Cap
- HKIT 39.8M
- PYPD 36.0M
- IPO Year
- HKIT 2023
- PYPD 2020
- Fundamental
- Price
- HKIT $1.43
- PYPD $3.40
- Analyst Decision
- HKIT
- PYPD Strong Buy
- Analyst Count
- HKIT 0
- PYPD 5
- Target Price
- HKIT N/A
- PYPD $11.40
- AVG Volume (30 Days)
- HKIT 8.2K
- PYPD 214.9K
- Earning Date
- HKIT 04-29-2025
- PYPD 08-13-2025
- Dividend Yield
- HKIT N/A
- PYPD N/A
- EPS Growth
- HKIT N/A
- PYPD N/A
- EPS
- HKIT N/A
- PYPD N/A
- Revenue
- HKIT $2,904,950.00
- PYPD N/A
- Revenue This Year
- HKIT N/A
- PYPD N/A
- Revenue Next Year
- HKIT N/A
- PYPD N/A
- P/E Ratio
- HKIT N/A
- PYPD N/A
- Revenue Growth
- HKIT N/A
- PYPD N/A
- 52 Week Low
- HKIT $1.15
- PYPD $2.30
- 52 Week High
- HKIT $1.86
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- HKIT 60.28
- PYPD 51.00
- Support Level
- HKIT $1.33
- PYPD $3.34
- Resistance Level
- HKIT $1.45
- PYPD $3.53
- Average True Range (ATR)
- HKIT 0.05
- PYPD 0.15
- MACD
- HKIT 0.01
- PYPD -0.04
- Stochastic Oscillator
- HKIT 100.00
- PYPD 14.68
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.